• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从天然产物中发现药物。

Drug discovery from natural products.

作者信息

Gullo Vincent P, McAlpine James, Lam Kin S, Baker Dwight, Petersen Frank

机构信息

Cetek Corporation, 260 Cedar Hill Street, Marlborough, MA 01752, USA.

出版信息

J Ind Microbiol Biotechnol. 2006 Jul;33(7):523-31. doi: 10.1007/s10295-006-0107-2. Epub 2006 Mar 17.

DOI:10.1007/s10295-006-0107-2
PMID:16544162
Abstract

Natural product compounds are the source of numerous therapeutic agents. Recent progress to discover drugs from natural product sources has resulted in compounds that are being developed to treat cancer, resistant bacteria and viruses and immunosuppressive disorders. Many of these compounds were discovered by applying recent advances in understanding the genetics of secondary metabolism in actinomycetes, exploring the marine environment and applying new screening technologies. In many instances, the discovery of a novel natural product serves as a tool to better understand targets and pathways in the disease process. This review describes recent progress in drug discovery from natural sources including several examples of compounds that inhibit novel drug targets.

摘要

天然产物化合物是众多治疗药物的来源。近期从天然产物来源发现药物的进展已产生了一些正在开发用于治疗癌症、耐药细菌和病毒以及免疫抑制性疾病的化合物。其中许多化合物是通过应用在放线菌次级代谢遗传学理解方面的最新进展、探索海洋环境以及应用新的筛选技术而发现的。在许多情况下,新型天然产物的发现可作为更好地理解疾病过程中的靶点和途径的工具。本综述描述了从天然来源发现药物的近期进展,包括一些抑制新型药物靶点的化合物实例。

相似文献

1
Drug discovery from natural products.从天然产物中发现药物。
J Ind Microbiol Biotechnol. 2006 Jul;33(7):523-31. doi: 10.1007/s10295-006-0107-2. Epub 2006 Mar 17.
2
Advances in drug discovery and biochemical studies.药物发现与生化研究的进展
Trends Parasitol. 2007 May;23(5):223-9. doi: 10.1016/j.pt.2007.03.005. Epub 2007 Mar 23.
3
[Chemical study on bioactive natural products of novel structural types].[新型结构类型生物活性天然产物的化学研究]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Aug;26(4):347-50.
4
Drug discovery and natural products: end of an era or an endless frontier?药物发现与天然产物:一个时代的终结还是无尽的前沿?
Science. 2009 Jul 10;325(5937):161-5. doi: 10.1126/science.1168243.
5
Unlocking the potential of natural products in drug discovery.挖掘天然产物在药物研发中的潜力。
Microb Biotechnol. 2019 Jan;12(1):55-57. doi: 10.1111/1751-7915.13351. Epub 2018 Dec 19.
6
Bioactive natural products from Chinese marine flora and fauna.中国海洋动植物中的生物活性天然产物。
Acta Pharmacol Sin. 2012 Sep;33(9):1159-69. doi: 10.1038/aps.2012.110. Epub 2012 Sep 3.
7
Using genomics to deliver natural products from symbiotic bacteria.利用基因组学从共生细菌中提取天然产物。
Genome Biol. 2005;6(9):232. doi: 10.1186/gb-2005-6-9-232. Epub 2005 Aug 31.
8
Natural product hybrids as new leads for drug discovery.天然产物杂合体作为药物发现的新先导物。
Angew Chem Int Ed Engl. 2003 Sep 5;42(34):3996-4028. doi: 10.1002/anie.200200553.
9
Marinopyrroles: Unique Drug Discoveries Based on Marine Natural Products.海洋吡咯烷酮类化合物:基于海洋天然产物的独特药物发现。
Med Res Rev. 2016 Jan;36(1):169-89. doi: 10.1002/med.21359. Epub 2015 Aug 31.
10
Evolva breeds small molecule drugs au naturel.Evolva公司采用自然方法培育小分子药物。
Chem Biol. 2009 Jun 26;16(6):577-8. doi: 10.1016/j.chembiol.2009.06.004.

引用本文的文献

1
Wogonin inhibits radiation-induced DNA damage repair in hepatocellular carcinoma cells by upregulating p21.汉黄芩素通过上调p21抑制肝癌细胞中辐射诱导的DNA损伤修复。
Korean J Physiol Pharmacol. 2025 Jul 1;29(4):419-429. doi: 10.4196/kjpp.24.213. Epub 2025 Feb 6.
2
Harnessing the potential of chloroplast-derived expression elements for enhanced production of cellulases in .利用叶绿体衍生表达元件的潜力以提高纤维素酶的产量 。 (原文最后“in”后面缺少具体内容)
PeerJ. 2025 Jan 31;13:e18616. doi: 10.7717/peerj.18616. eCollection 2025.
3
Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis.

本文引用的文献

1
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent.NPI-2358是一种微管解聚剂:作为肿瘤血管破坏剂活性的体外证据。
Anticancer Drugs. 2006 Jan;17(1):25-31. doi: 10.1097/01.cad.0000182745.01612.8a.
2
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.一种新型口服活性蛋白酶体抑制剂通过不同于硼替佐米的机制诱导多发性骨髓瘤细胞凋亡。
Cancer Cell. 2005 Nov;8(5):407-19. doi: 10.1016/j.ccr.2005.10.013.
3
HSP90 and the chaperoning of cancer.
鞘脂生物合成通量的改变和脂蛋白转运导致反式脂肪诱导的动脉粥样硬化。
Cell Metab. 2025 Jan 7;37(1):274-290.e9. doi: 10.1016/j.cmet.2024.10.016. Epub 2024 Nov 14.
4
In Silico Approach: Anti-Tuberculosis Activity of Caespitate in the H37Rv Strain.计算机模拟方法:丛生草提取物对H37Rv菌株的抗结核活性
Curr Issues Mol Biol. 2024 Jun 27;46(7):6489-6507. doi: 10.3390/cimb46070387.
5
The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study.甜菜碱与放射疗法在前列腺癌细胞系中的协同作用:一项体外研究。
Mol Biol Rep. 2023 Nov;50(11):9307-9314. doi: 10.1007/s11033-023-08828-0. Epub 2023 Oct 9.
6
Naturally Occurring Organohalogen Compounds-A Comprehensive Review.天然有机卤代化合物综述。
Prog Chem Org Nat Prod. 2023;121:1-546. doi: 10.1007/978-3-031-26629-4_1.
7
Extremophilic Fungi from Marine Environments: Underexplored Sources of Antitumor, Anti-Infective and Other Biologically Active Agents.海洋环境中的极端真菌:抗肿瘤、抗感染和其他生物活性物质的未充分探索来源。
Mar Drugs. 2022 Jan 10;20(1):62. doi: 10.3390/md20010062.
8
Anti-Inflammatory and Anticancer Properties of Birch Bark-Derived Betulin: Recent Developments.桦树皮衍生的桦木醇的抗炎和抗癌特性:最新进展
Plants (Basel). 2021 Dec 3;10(12):2663. doi: 10.3390/plants10122663.
9
Molecular Modeling Applied to the Discovery of New Lead Compounds for P2 Receptors Based on Natural Sources.基于天然来源的分子建模在P2受体新型先导化合物发现中的应用
Front Pharmacol. 2020 Sep 29;11:01221. doi: 10.3389/fphar.2020.01221. eCollection 2020.
10
Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.天然类黄酮作为潜在的血管紧张素转换酶 2 抑制剂用于抗 SARS-CoV-2。
Molecules. 2020 Sep 1;25(17):3980. doi: 10.3390/molecules25173980.
热休克蛋白90与癌症的伴侣蛋白作用
Nat Rev Cancer. 2005 Oct;5(10):761-72. doi: 10.1038/nrc1716.
4
Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.细菌肽脱甲酰基酶抑制剂:一类新型抗菌剂。
Curr Med Chem. 2005;12(14):1607-21. doi: 10.2174/0929867054367194.
5
Recent developments in the discovery of novel oxazolidinone antibacterials.新型恶唑烷酮类抗菌药物的最新发现进展
Curr Opin Drug Discov Devel. 2005 Jul;8(4):469-77.
6
Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1.血管细胞黏附分子1共翻译易位的选择性抑制
Nature. 2005 Jul 14;436(7048):290-3. doi: 10.1038/nature03670.
7
A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum.一种内质网蛋白易位的底物特异性抑制剂。
Nature. 2005 Jul 14;436(7048):285-9. doi: 10.1038/nature03821.
8
Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents.热休克蛋白90抑制剂作为新型癌症化疗药物。
Expert Opin Emerg Drugs. 2002 Oct;7(2):277-88. doi: 10.1517/14728214.7.2.277.
9
FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.新型免疫调节剂FTY720通过对1-磷酸鞘氨醇受体的激动活性,抑制淋巴细胞从次级淋巴组织和胸腺中逸出。
Pharmacol Ther. 2005 Dec;108(3):308-19. doi: 10.1016/j.pharmthera.2005.05.002. Epub 2005 Jun 13.
10
Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor.新型海洋来源蛋白酶体抑制剂盐孢霉素A(NPI - 0052)的构效关系研究
J Med Chem. 2005 Jun 2;48(11):3684-7. doi: 10.1021/jm048995+.